Denali Therapeutics
DNLI
DNLI
189 hedge funds and large institutions have $2.8B invested in Denali Therapeutics in 2022 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 67 increasing their positions, 69 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
189
Holders Change
-23
Holders Change %
-10.85%
% of All Funds
2.99%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
19
Increased
67
Reduced
69
Closed
40
Calls
$818K
Puts
$1.8M
Net Calls
-$986K
Net Calls Change
+$7.7M
Top Buyers
Top Sellers
| 1 |
1
BAMCO Inc
New York
|
$21.1M |
| 2 |
2
Jennison Associates
New York
|
$0 |
| 3 |
GGHC
3
Gilder Gagnon Howe & Co
New York
|
$84.3M |
| 4 |
CM
4
Crestline Management
Fort Worth,
Texas
|
$240M |
| 5 |
5
Marshall Wace
London,
United Kingdom
|
$4.92M |
